HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

AbstractBACKGROUND:
Patients with hepatocellular carcinoma (HCC) caused by dual hepatitis B and C virus (HBV, HCV) infection may constitute a distinct disease group that is different from patients with single virus infection. This study compared the clinical characteristics and outcomes of patients with HBV, HCV and dual virus infection.
METHODS:
A prospective database of 1215 HCC patients with chronic hepatitis B, C or dual virus infection was investigated.
RESULTS:
Patients with HCV infection (n=388) were significantly older (mean age, 69 years) than patients with dual virus (n=75, 65 years) and HBV (n=752; 60 years) infection (P<0.0001). The male-to-female ratios for the HBV, dual virus and HCV groups were 5.2, 3.4 and 1.3 respectively (P<0.0001). Patients in the HBV group more often had higher total tumour volume (mean, 409 cm(3)) than those in the dual virus group (244 cm(3)) and HCV (168 cm(3)) group (P<0.0001). No significant differences of the severity of liver cirrhosis, performance status, cancer staging and tumour cell differentiation were noted among the three groups. Patients in the HCV group had a significantly poor survival in comparison with the HBV group only in the subset of patients with small tumour volume (<50 cm(3)) in the Cox proportional hazards model (relative risk, 1.44; P=0.041).
CONCLUSIONS:
Dual HBV and HCV virus infection does not accelerate the speed of HCC formation in patients with chronic hepatitis B, and appears to have a modified course of carcinogenesis pathway that is diverted away from the biological behaviour of HBV and HCV infection.
AuthorsTeh-Ia Huo, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Chia-Yang Hsu, Pui-Ching Lee, Wing-Yiu Lui, Che-Chuan Loong, Jen-Huei Chiang, Yi-You Chiou, Shou-Dong Lee
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 29 Issue 5 Pg. 767-73 (May 2009) ISSN: 1478-3231 [Electronic] United States
PMID19018974 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (etiology, mortality, physiopathology)
  • Female
  • Hepatitis B (complications)
  • Hepatitis C (complications)
  • Humans
  • Liver Neoplasms (etiology, mortality, physiopathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prospective Studies
  • Risk Assessment
  • Survival Analysis
  • Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: